Evidence map›Paper›PMID 30882465›Full record

ArticleChinese medical journal2019

A multi-center cross-sectional study on blood purification among adult patients in intensive care unit in China: a study protocol.

Yang Gao, Zhi-Dong Qi, Rui-Jin Liu, Hai-Tao Liu, Qiu-Yuan Han, Xing Zhang, Rui Huang, Ming Li, Zhen-Yu Yang, Jun-Bo Zheng and 5 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Chinese medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Yang GaoDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Zhi-Dong QiDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Rui-Jin LiuDepartment of Critical Care Medicine, The Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, China.
Hai-Tao LiuDepartment of Critical Care Medicine, The Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, China.
Qiu-Yuan HanDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Xing ZhangDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Rui HuangDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Ming LiDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Zhen-Yu YangDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Jun-Bo ZhengDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Jing-Dong QuDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Si-Cong WangDepartment of Critical Care Medicine, The Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, China.
Yan-Song LiuDepartment of Critical Care Medicine, The Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, China.
Hong-Liang WangDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
Kai-Jiang YuInstitute of Critical Care Medicine in Sino Russian Medical Research Center of Harbin Medical University, Harbin, Heilongjiang 150081, China.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CNFirst Affiliated Hospital of Harbin Medical University · CNThird Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood purification (BP) is one of the most important rescue measures for patients with critical illness in the intensive care unit (ICU), especially for those with acute kidney injury. The purpose of this nationwide survey was to reveal the real world of current BP practice in different ICUs all over China. This study was designed to be a multi-center cross-sectional study.

methodsAll adult patients (over 18 years of age), who were admitted to ICU and required BP in 35 sub-centers across China were included during 30-day survey period in 2018. Demographic characteristics and clinical data were recorded including the timing of treatment initiation, indications, modality, relative contraindication, establishment of vascular access, selection of filter/membrane, settings, anti-coagulation, executive department, complication, intake, and output. DISCUSSION: This nationwide survey may contribute to reveal the real world of current BP practice in different ICUs all over China.

trial registrationChinese Clinical Trial Registry, ChiCTR-EOC-17013119; http://www.chictr.org.cn/showproj.aspx?proj=22487.

Indexed as

ChinaCross-Sectional StudiesHemofiltrationHumansIntensive Care UnitsModels, Theoretical

Identifiers

PMID30882465
PMCPMC6511420
OpenAlexW2924440865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.